Yland JJ, McKinnon CJ, Hatch EE, Eisenberg ML, Nillni YI, Rothman KJ, Wise LA. A prospective study of male depression, psychotropic medication use, and fecundability. Am J Mens Health. 2022 Jan;16(1):155798832. doi: 10.1177/15579883221075520
Park EM, Check DK, Yopp JM, Deal AM, Edwards TP, Rosenstein DL. An exploratory study of end-of-life prognostic communication needs as reported by widowed fathers due to cancer. Psychooncology. 2015 Nov;24(11):1471-6. doi: 10.1002/pon.3757
Ward MA, Fang G, Richards KL, Walko CM, Earnshaw SR, Happe LE, Blalock S. Treatment interruption and regimen change in first-generation vs. second-generation tyrosine kinase inhibitors used as first-line therapy for chronic myeloid leukemia. JHEOR. 2015 Apr;2(2):181-91.
Davis KL, Gutierrez B, Zyczynski T, Kaye JA. Real-world treatment patterns in men with castration-resistant prostate cancer receiving docetaxel. JHEOR. 2015 Jan 6;2(2):119-30. doi: 10.36469/9894
Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013 Apr;22(4):745-55. doi: 10.1002/pon.3055
Sharp L, Cotton S, Carsin AE, Gray N, Thornton A, Cruickshank M, Little J, TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the trial of management of borderline and other low-grade abnormal smears (TOMBOLA). Psychooncology. 2013 Feb;22(2):368-80. doi: 10.1002/pon.2097
Adams, Jr SG, Britt (DiBenedetti) DM, Godding PR, Khansur TI, Bulcourf BB. Relative contribution of the Karnofsky Performance Status Scale in a multi-measure assessment of quality of life in cancer patients. Psychooncology. 1995 Oct;4(3):239-46. doi: 10.1002/pon.2960040310